| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/20/2000 | WO2000021964A1 Imidazo-benzazepines having cardiovascular, antitumor, antiinfective and anfiinflammatory activity |
| 04/20/2000 | WO2000021963A1 Il-8 receptor antagonists |
| 04/20/2000 | WO2000021961A1 Imidazo-isoquinoline compounds, their compositions and uses |
| 04/20/2000 | WO2000021959A1 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 04/20/2000 | WO2000021920A1 Diaminopropionic acid derivatives |
| 04/20/2000 | WO2000021910A2 1,2-disubstituted cyclopropanes |
| 04/20/2000 | WO2000021567A1 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides |
| 04/20/2000 | WO2000021549A1 A method of inducing or enhancing chondrogenesis with extracellular matrix containing gdf-5 |
| 04/20/2000 | WO2000021542A1 Methods for stimulating bone formation |
| 04/20/2000 | WO2000021541A1 Process for the preparation of oral pharmaceutical compositions comprising biphosphonates |
| 04/20/2000 | WO2000021540A1 Compositions containing diphosphonic acids |
| 04/20/2000 | WO2000021535A1 Pharmaceutical formulations for use in estrogen deprivation syndrome |
| 04/20/2000 | WO2000021532A1 Methods for inhibiting bone resorption |
| 04/20/2000 | WO2000021525A2 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 04/20/2000 | WO2000021524A1 Pufa supplements |
| 04/20/2000 | WO2000021523A1 Methods for regulating bone formation |
| 04/20/2000 | WO2000021503A1 Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin |
| 04/20/2000 | WO2000005245A3 Inhibitors of urokinase and blood vessel formation |
| 04/20/2000 | WO1999066913A3 Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome, comprising propionyl-l-carnitine and genistein |
| 04/20/2000 | WO1999048868A9 Heterocyclic classes of compounds for the modulating tyrosine protein kinase |
| 04/20/2000 | DE19847823A1 New 3-(Hetero)aryl-5-aminosulfonyl-1,2,4-thiadiazole derivatives useful as inhibitors of IL-1beta production in treatment of e.g. leukemia, septic shock, hepatitis, AIDS and diseases of locomotor system |
| 04/20/2000 | DE19845372A1 Verwendung von Katecholderivaten als Proteinaseninhibitoren Using catechol as proteinase inhibitors |
| 04/20/2000 | DE19844111A1 Novel antisense nucleic acids targeted to specific sequences within the ICAM-1 gene, useful for treating inflammation and metastasis |
| 04/20/2000 | CA2653503A1 The use of ara as a supplement for a lactating woman |
| 04/20/2000 | CA2347968A1 Follistatin-related protein zfsta2 |
| 04/20/2000 | CA2347653A1 Novel cell signaling polypeptides and nucleic acids |
| 04/20/2000 | CA2347225A1 Pharmaceutical formulations for use in estrogen deprivation syndrome |
| 04/20/2000 | CA2347092A1 1,2-disubstituted cyclopropanes |
| 04/20/2000 | CA2346775A1 Protein kinase homologs |
| 04/20/2000 | CA2346542A1 Imidazo-benzazepines having cardiovascular, antitumor, antiinfective and antiinflammatory activity |
| 04/20/2000 | CA2346414A1 Imidazo-isoquinoline compounds, their compositions and uses |
| 04/20/2000 | CA2346066A1 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides |
| 04/20/2000 | CA2346038A1 Methods for inhibiting bone resorption |
| 04/20/2000 | CA2346036A1 Methods for regulating bone formation |
| 04/20/2000 | CA2346031A1 Methods for stimulating bone formation |
| 04/20/2000 | CA2345885A1 Bone morphogenic protein-induced genes and polypeptides, and their use in diagnostic and therapeutic methods |
| 04/20/2000 | CA2314004A1 Matrix-remodeling genes |
| 04/19/2000 | EP0994093A1 Polyhydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same |
| 04/19/2000 | EP0993456A1 2-substituted 4,5-diaryl imidazoles |
| 04/19/2000 | EP0993449A1 Quinoline derivatives as pde iv and/or tnf inhibitors |
| 04/19/2000 | EP0993442A1 Hydrazine derivatives |
| 04/19/2000 | EP0880524B1 Adenosin antagonists, method of preparing them and their use as drugs |
| 04/19/2000 | CN1251092A Certain cyclic thio substitued acylaminoacid amide derivatives |
| 04/19/2000 | CN1251043A Use of protein extractable from animal organs for prepn. of medicaments for treatment of pathological conditions |
| 04/19/2000 | CN1250776A Heterodicyclic compound derivatives |
| 04/19/2000 | CN1250661A Medicinal composition for treating bone fracture and its preparing process |
| 04/19/2000 | CN1250660A Liquid medicine for treating wound and pain |
| 04/19/2000 | CN1051548C Heterobicyclic derivatives, pharmaceutical compositions contg. same, mfg. method and use thereof |
| 04/19/2000 | CN1051471C Medicine compositon for curing osteoporosis |
| 04/19/2000 | CN1051458C Medicine for treating bone and joint diseases and method for preparing same |
| 04/19/2000 | CN1051457C Medicine for rheumatic arthritis and its prepn. method |
| 04/18/2000 | US6051686 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| 04/18/2000 | US6051577 N-7-heterocyclyl pyrrolo[2,3-D]pyrimidines and the use thereof |
| 04/18/2000 | US6051228 Antibodies against human CD40 |
| 04/13/2000 | WO2000020592A1 Glucose-dependent insulinotropic peptide for use as an osteotropic hormone |
| 04/13/2000 | WO2000020591A2 Tgf-beta superfamily mutant members, including morphogenic proteins |
| 04/13/2000 | WO2000020559A1 Method for the treatment of chemonucleolysis |
| 04/13/2000 | WO2000020449A2 MODIFIED TGF-β SUPERFAMILY PROTEINS |
| 04/13/2000 | WO2000020447A2 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses |
| 04/13/2000 | WO2000020440A1 Caspases and apoptosis |
| 04/13/2000 | WO2000020434A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 04/13/2000 | WO2000020402A1 Chemical compounds |
| 04/13/2000 | WO2000020398A1 Biphenylene lactams as prostaglandin receptor ligands |
| 04/13/2000 | WO2000020389A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 04/13/2000 | WO2000020378A1 Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
| 04/13/2000 | WO2000020371A1 Prostaglandin receptor ligands |
| 04/13/2000 | WO2000020021A1 Repair of larynx, trachea, and other fibrocartilaginous tissues |
| 04/13/2000 | WO2000020015A1 Plant extracts for the treatment of increased bone resorption |
| 04/13/2000 | WO2000020014A1 Plant extracts for the treatment of increased bone resorption |
| 04/13/2000 | WO2000020008A1 Use of bisphosphonic acid derivatives for preparing a medicine for treating lameness |
| 04/13/2000 | WO2000020007A1 Method and compositions for increasing bone mass |
| 04/13/2000 | WO2000020000A1 Controlled release oral preparations of esculetin and its derivatives |
| 04/13/2000 | WO2000019989A2 Use of catechol derivatives as proteinase inhibitors |
| 04/13/2000 | WO1999064565A9 Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells |
| 04/13/2000 | CA2657302A1 Modified tgf-.beta. superfamily proteins |
| 04/13/2000 | CA2346456A1 Method and compositions for increasing bone mass |
| 04/13/2000 | CA2346445A1 Biphenylene lactams as prostaglandin receptor ligands |
| 04/13/2000 | CA2346443A1 Prostaglandin receptor ligands |
| 04/13/2000 | CA2346375A1 Method for the treatment of chemonucleolysis |
| 04/13/2000 | CA2346019A1 Use of catechol derivatives as proteinase inhibitors |
| 04/13/2000 | CA2345881A1 Bone marrow-derived serum proteins |
| 04/13/2000 | CA2345377A1 Novel secreted proteins and polynucleotides encoding them |
| 04/13/2000 | CA2345133A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 04/13/2000 | CA2344266A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 04/13/2000 | CA2343698A1 Repair of larynx, trachea, and other fibrocartilaginous tissues |
| 04/13/2000 | CA2341374A1 Quinoline and quinazoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 04/12/2000 | EP0992493A1 Substituted benzoylpiperidine derivatives and their use as Neurokinin antagonists |
| 04/12/2000 | EP0991753A1 Protease inhibitors |
| 04/12/2000 | EP0991660A1 Deuterated cyclosporine analogs and their use as immunomodulating agents |
| 04/12/2000 | EP0991653A1 Novel compounds |
| 04/12/2000 | EP0991636A1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 04/12/2000 | EP0991630A1 Crystalline roxifiban |
| 04/12/2000 | EP0991628A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56?lck TYROSINE KINASES |
| 04/12/2000 | EP0991618A1 Selective thyroid hormone analogs |
| 04/12/2000 | EP0991413A1 Composition comprising a hydrolysed collagen protein and glucosamine for the treatment of arthroses |
| 04/12/2000 | EP0707566B1 Novel structural analogues of vitamin d |
| 04/12/2000 | CN1250445A Sulfamide-metalloprotease inhibitors |
| 04/12/2000 | CN1250374A Therapeutic combination of mineral and vitamin in units of liquid preparation for oral administration |
| 04/11/2000 | US6048964 Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
| 04/11/2000 | US6048897 Lipoxin compounds and their use in treating cell proliferative disorders |